$GILD Recent News Health-care inflation heating back up

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2014 at 12:58 PM

$GILD Recent News

Health-care inflation heating back up 10:24 a.m. Today - blogs.marketwatch.com
Medtronic’s real problem is innovation, not taxation 6:45 a.m. June 19, 2014 - Tim Mullaney
Rival to Gilead's pricey Sovaldi expected to hit market later this year 7:28 a.m. June 18, 2014 - blogs.marketwatch.com
Tyson falls on Hillshire deal; Apple gains post-split 3:49 p.m. June 9, 2014 - Saumya Vaishampayan
Lobbyists for insurers, big pharma trade barbs over high drug costs 3:10 p.m. June 2, 2014 - blogs.marketwatch.com
Industry titan UnitedHealth misses boom in sector 10:53 a.m. May 29, 2014 - Russ Britt
Gilead says its drug gives hepatitis C patients more cost-effective cure 5:06 p.m. April 30, 2014 - blogs.marketwatch.com
Why a diverse ETF portfolio is right for these times 6:29 a.m. April 30, 2014 - John Prestbo
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
What Obamacare problems? Aetna results not showing any ill effects 12:34 p.m. April 24, 2014 - blogs.marketwatch.com
U.S. stocks tumble; S&P 500 ends 6-day run 4:46 p.m. April 23, 2014 - Anora Mahmudova
Apple, Facebook stuck in red ahead of earnings 3:02 p.m. April 23, 2014 - Saumya Vaishampayan
U.S. stock futures pause after six-session win streak 8:57 a.m. April 23, 2014 - Sara Sjolin
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Apple, Facebook, Boeing are stocks to watch 5:30 a.m. April 23, 2014 - Sue Chang
Gilead shares climb; AT&T, Amgen shares fall 5:55 p.m. April 22, 2014 - Myra P. Saefong
Gilead scores big on earnings with new drug, but investors getting wary 5:46 p.m. April 22, 2014 - blogs.marketwatch.com
Gilead earnings buoyed by Hepatitis-C drug 5:04 p.m. April 22, 2014 - Anna Prior
Gilead Sciences shares up 4.5% in after-hours trade 4:35 p.m. April 22, 2014 - Myra P. Saefong
Gilead beats expectations; Sovaldi sales hit $2.3 bln 4:22 p.m. April 22, 2014 - Claudia Assis

Two Women Crack Top 10 in CFO Pay 10:30 a.m. Today - The Wall Street Journal Interactive Edition
Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights - Analyst Blog 4:45 p.m. June 23, 2014 - Zacks.com
RegeneRx and Lee's Pharmaceutical Dry Eye Drug Progresses - Analyst Blog 12:10 p.m. June 23, 2014 - Zacks.com
Cubist Gains FDA Approval for Sivextro - Analyst Blog 11:50 a.m. June 23, 2014 - Zacks.com
Novo Nordisk Reveals Positive Data on Victoza 3 mg - Analyst Blog 11:30 a.m. June 23, 2014 - Zacks.com
Analyzing The Hepatitis C Market Size: Why It May Have Bullish Implications For Gilead 11:15 a.m. June 23, 2014 - Seeking Alpha
Stock Market News for June 23, 2014 - Market News 10:06 a.m. June 23, 2014 - Zacks.com
Weekly CFO Sells Highlight: Facebook Inc, Workday Inc, Gilead Sciences Inc. 9:49 a.m. June 23, 2014 - GuruFocus.com
Alkermes plc (ALKS) Jumps: Stock Rises 5.7% - Tale of the Tape 9:21 a.m. June 23, 2014 - Zacks.com
Strength Seen in Cara Therapeutics Inc. (CARA) as Stock Rallies 19.60% - Tale of the Tape 8:44 a.m. June 23, 2014 - Zacks.com
Merrimack Pharmaceuticals (MACK) Crumbles: Stock Tanks by 11.3% - Tale of the Tape 8:33 a.m. June 23, 2014 - Zacks.com
Weekly Insider Sells Highlight: FB, NFLX, WDAY, GILD 8:53 p.m. June 22, 2014 - GuruFocus.com
AstraZeneca's Naloxegol Data Published - Analyst Blog 6:00 p.m. June 20, 2014 - Zacks.com
Alnylam-TAP Collaborate for AAT Candidate - Analyst Blog 4:45 p.m. June 20, 2014 - Zacks.com
Dividend Yield Vs. Dividend Growth Revisited - Does It Matter? 4:26 p.m. June 20, 2014 - Seeking Alpha
OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog 3:50 p.m. June 20, 2014 - Zacks.com
Merge Healthcare: Updated Research Report - Analyst Blog 2:55 p.m. June 20, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: DIS, BIDU, GILD 2:44 p.m. June 20, 2014 - TheStreet.com
Illumina: Updated Research Report - Analyst Blog 2:30 p.m. June 20, 2014 - Zacks.com
Achillion Could Win Idenix's Mystery Suitor: Analyst 11:44 a.m. June 20, 2014 - Investors Business Daily

Gilead Sciences to Present at the Wells Fargo Healthcare Conference on Tuesday, June 17 5:00 p.m. June 16, 2014 - BusinessWire - BZX
Gilead Announces Phase 3 Data Showing That the Fixed-Dose Combination of Ledipasvir/Sofosbuvir Achieved 100 Percent Sustained Virologic Response (SVR12) Among Patients with Chronic Hepatitis C in Japan 8:00 p.m. June 15, 2014 - BusinessWire - BZX
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors 3:30 p.m. June 13, 2014 - PR Newswire - PRF
Critical Alerts For Ralph Lauren, Rackspace Hosting, Gilead Sciences, Fortinet, and Express Scripts Technology Released By InvestorsObserver 9:31 a.m. June 13, 2014 - PR Newswire - PRF
Prescription for Profit: Pharma-Biotech Industry Continues Mega-Billion Dollar Merger & Acquisition Binge, an Industrial Info News Alert 6:15 a.m. June 11, 2014 - Marketwire
Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, June 10 5:00 p.m. June 9, 2014 - BusinessWire - BZX
Gilead Announces Updated Phase 2 Results for Investigational GS-9973 in Relapsed Chronic Lymphocytic Leukemia 8:30 a.m. June 3, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene 5:10 a.m. May 28, 2014 - PR Newswire - PRF
AHF: ‘Negligent Corporate Welfare’ Pushes Gilead to Top of S&P 500 5:40 p.m. May 22, 2014 - BusinessWire - BZX
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape 12:38 p.m. May 22, 2014 - PR Newswire - PRF
Gilead’s Investigational GS-5806 Reduces Viral Load and Clinical Symptoms in Phase 2 Respiratory Syncytial Virus (RSV) Challenge Study in Adults 5:00 p.m. May 20, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 2014 UBS Healthcare Conference on Tuesday, May 20 5:00 p.m. May 19, 2014 - BusinessWire - BZX
Critical Alerts For Goldman Sachs, Noodles & Company, Starbucks, Gilead Sciences, and Time Warner Cable Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference on Wednesday, May 14 5:00 p.m. May 13, 2014 - BusinessWire - BZX
Gilead Announces Phase 1 Data for Investigational Therapy, GS-6615, in Patients with Long QT-3 Syndrome 4:31 p.m. May 9, 2014 - BusinessWire - BZX
Cancer Diagnostics Partnering Terms and Agreements 5:41 p.m. May 7, 2014 - PR Newswire - PRF
Gilead Announces $5 Billion Share Repurchase Program 5:17 p.m. May 7, 2014 - BusinessWire - BZX
Medivir: a Supplemental New Drug Application Has Been Submitted to the U.S. FDA for Simeprevir in Combination with Sofosbuvir 8:06 a.m. May 7, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pye-Barker's Bold Play in Florida Fire Safety Market

A Strategic Spark in Fire Protection Well, here's a move that lights up the fire protection sector. Pye-Barker Fire & Safety, known for being the top dog in U.S. fire safety services, decided to scoop up St. John's Fire Equipment down in Florida. Let's just say, they're not putting out any fires here—more like stoking a strategic blaze. This acquisition positions...

Writesonic Unveils Tools to Tame AI Information Spread

Grappling with AI's Take on Your Brand So here's the juicy bit. In a world where AI blabs about brands, Writesonic is rolling out shiny tools to let marketers keep tabs on the chatter. You know the score—AI goes off on its own sometimes, spewing all sorts of comments, some true, some a bit off. Writesonic isn't just counting mentions anymore; it's digging into what AI...

Lynk's Zemprocitinib Set for RA Markets: NDA Accepted

A Step Closer for Zemprocitinib: Here's the Lowdown Surprise in the pharma skies as Lynk Pharmaceuticals takes a major leap with its new gem, zemprocitinib, entering the regulatory review phase. The center buzzed on November 4 when China's NMPA gave the coveted nod to this New Drug Application (NDA). Seems the race for rheumatoid arthritis (RA) treatments just got a...

XCMG Spurs 'AI + Construction' Innovation at Event

XCMG's Big Push for Smarter Machinery China's construction machinery titan XCMG just wrapped up a fireworks show of innovation in Xuzhou, highlighting some sharp AI-driven machinery projects. Their recent 'AI + Construction Machinery' competition pulled in minds from over 20 countries, all aiming to rethink how these hulking machines operate. AI and Machinery: A Match...

Empower Brokerage Draws Talent to North Texas Job Fair

Shakeup at the North Texas Job Fair Slinging insurance ain't everyone's dream gig, but some folks find their calling where money meets meaning. The North Texas Job Fair, already known for its heavy foot traffic, saw a unique player strutting their stuff this year—Empower Brokerage. This family-owned insurance agency wasn't just slinging corporate pitch; they offered a...

MAURE Injects Fresh Style into Holiday Gatherings

Setting the Holiday Mood, MAURE Style Ever feel like your holiday gatherings need a little extra flair? Enter MAURE and their 2026 holiday collection, promising to make your seasonal get-togethers anything but ordinary. This is all about bringing some fresh style to your celebrations. They've got decorative Swedish birchwood trays that scream elegance, and their signature...

6K Lands $250M Loan for U.S. Battery Supply Boost

U.S. Battery Supply Set for a Boost Ah, the thrill of a conditional commitment—it's not quite a done deal, but it's a step in the right direction. 6K Inc., with its roots in Massachusetts, is on the brink of transforming the American battery supply chain after announcing a whopping $250 million loan commitment from none other than the U.S. Department of War. This move...

Blue Angels Super Hornet Makes Historic Retirement

The Palm Springs Air Museum is set to host a retirement party that could only be described as larger than life, and not because they've got a cake big enough for a 30th birthday bash. Nope, the real star is a jet—specifically, the Blue Angels F/A-18 Super Hornet that got its share of screen time in Top Gun: Maverick. First Public Retreat for a Super Hornet Saturday,...

Shield's $5.3B Bet on Echodyne Eyes New Heights

Defense Expansion in the Drone Era Alright, here's the big scoop from Kirkland, Washington—Shield’s just made an aggressive move to gobble up Echodyne Corp. for a cool $5.3 billion, and trust me, this isn’t small potatoes. This merger is setting the stage for Shield's expansion into the radar and counter-drone spheres, two red-hot sectors screaming for innovation...

Priority Software Acquires Fireberry to Boost AI Vision

Another Big Play in the AI-Driven Business Landscape Here we go, folks. Priority Software just made a move that's gonna shake up the AI business management scene. They’ve acquired Fireberry, a CRM company that's seen some success in the AI world. Now, this ain't just some small-scale adjustment; it's an all-in bet on AI to bolster their existing platforms. What's...